Lund, Sweden

Mikael Dohlsten


Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 215(Granted Patents)


Company Filing History:


Years Active: 1999-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Mind of Mikael Dohlsten: Pioneering Advances in Superantigen Research

Introduction: Mikael Dohlsten, an accomplished inventor based in Lund, Sweden, has made significant contributions to the field of immunology through his inventive work involving superantigens. With a portfolio of six patents, Dohlsten's innovative approaches have the potential to transform therapeutic strategies for various diseases.

Latest Patents: Among his notable inventions, Dohlsten holds patents related to modified chimeric superantigens. His recent patent describes a conjugate between a target-seeking moiety and a modified superantigen. The invention emphasizes a wild-type superantigen (SA I) wherein an amino acid residue responsible for binding to T cell receptors (TCR) has been replaced while still maintaining the ability to activate T cells. Additionally, his work includes a therapeutic method utilizing modified superantigens and an antibody preparation designed to prevent interchain disulfide bonds for pharmaceutical purposes. Another noteworthy patent involves a method for treating diseases in mammals using a conjugate of a biospecific affinity counterpart and a peptide, derived from staphylococcal enterotoxin A, designed to enhance binding to MHC class II antigens.

Career Highlights: Dohlsten has been affiliated with prominent organizations such as Active Biotech AB and Pharmacia & Upjohn AB, where he honed his skills and collaborated on groundbreaking projects. His depth of knowledge in the field has allowed him to develop innovative solutions aimed at addressing complex medical challenges.

Collaborations: Throughout his career, Mikael has worked alongside esteemed colleagues including Terje Kalland and Lars B. Abrahmsen. These collaborations have further enriched his research and led to advancements in the understanding of superantigens and their applications in medicine.

Conclusion: Mikael Dohlsten stands out as a visionary inventor whose work on superantigens has the potential to significantly impact therapeutic approaches in immunology. With his ongoing research and innovative patents, Dohlsten continues to pave the way for new solutions in the treatment of diseases, demonstrating the vital role of inventors in the advancement of science and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…